Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 14, 2014 13:21 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Second Opioid Abuse Deterrent Product

NORTHVALE, N.J., Jan. 14, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") ("Elite") (OTCBB:ELTP) announced today the first dosing of a pivotal bioequivalence study in...
December 05, 2013 12:49 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Initiates Pilot Bioequivalence Study for ELI-201

NORTHVALE, N.J., Dec. 5, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") ("Elite") (OTCBB:ELTP) announced today the first dosing of a pilot bioequivalence study in...
November 26, 2013 07:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces Conversion of Treppel Bridge Loan to Convertible Note

NORTHVALE, N.J., Nov. 26, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that Jerry Treppel, Elite's Chairman of the Board, has elected to convert the...
November 14, 2013 16:23 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2014

Revenues Increase by 83%, Product Development Accelerating Conference Call Scheduled for Monday, November 18 at 3:00 PM ET NORTHVALE, N.J., Nov. 14, 2013 (GLOBE NEWSWIRE) -- Elite...
November 14, 2013 07:45 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. to Host Second Quarter Business Update Call on November 18, 2013

NORTHVALE, N.J., Nov. 14, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
October 16, 2013 07:45 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces Bridge Loan Facility

NORTHVALE, N.J., Oct. 16, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that it has entered into a credit line agreement ("Credit Line") with Nasrat...
October 08, 2013 07:45 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces Manufacturing and License Agreement for Twelve Generic Products

NORTHVALE, N.J., Oct. 8, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today the signing of a Manufacturing and License Agreement ("Agreement")...
September 18, 2013 07:51 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Announces First Shipment of Generic Naltrexone Hydrochloride

NORTHVALE, N.J., Sept. 18, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the initial shipment of naltrexone hydrochloride 50 mg tablets...
September 03, 2013 09:46 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th

NORTHVALE, N.J., Sept. 3, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), today announced it will be featured as a presenting company at the 15th Annual Rodman & Renshaw Global...
August 14, 2013 16:29 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2014

NORTHVALE, N.J., Aug. 14, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral abuse-resistant...